Active Ingredient History
Pneumococcal polysaccharide vaccine, sold under the brand name Pneumovax 23, is a pneumococcal vaccine that is used for the prevention of pneumococcal disease caused by the 23 serotypes of Streptococcus pneumoniae contained in the vaccine as capsular polysaccharides. It is given by intramuscular or subcutaneous injection. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Pneumococcal Infections (approved 1983)
Aged (Phase 4)
Aging (Early Phase 1)
Anemia, Sickle Cell (Phase 2)
Arthritis, Juvenile (Phase 2/Phase 3)
Arthritis, Rheumatoid (Phase 4)
Asthma (Phase 4)
Axial Spondyloarthritis (Phase 4)
Bone Marrow Transplantation (Phase 4)
Breast Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1)
Common Variable Immunodeficiency (Phase 2)
COVID-19 (Phase 4)
Crohn Disease (Phase 4)
Deficiency Diseases (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diphtheria (Phase 2)
Drugs, Investigational (Phase 2)
Haemophilus influenzae type b (Phase 2)
Healthy Volunteers (Phase 3)
Hematologic Diseases (Phase 2)
Hemolysis (Phase 4)
Hepatitis A (Phase 2)
Hepatitis B (Phase 2)
Herpes Zoster (Phase 3)
Herpes Zoster Vaccine (Phase 3)
HIV (Phase 4)
HIV-Associated Lipodystrophy Syndrome (Early Phase 1)
HIV Infections (Phase 4)
Immune Tolerance (Phase 2)
Immunization (Phase 2)
Infections (Phase 1/Phase 2)
Inflammation (Early Phase 1)
Inflammatory Bowel Diseases (Phase 2)
Influenza, Human (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Transplantation (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Leukemia, Myeloid, Acute (Phase 4)
Liver Transplantation (Phase 4)
Lung Diseases (Phase 4)
Lupus Erythematosus, Systemic (Phase 4)
Lymphoma (Phase 4)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Non-Hodgkin (Phase 4)
Meningitis (Phase 2)
Meningococcal Infections (Phase 4)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Pertussis Vaccine (Phase 2)
Pneumococcal Infections (Phase 4)
Pneumococcal Vaccines (Phase 3)
Pneumonia (Phase 4)
Pneumonia, Bacterial (Phase 1/Phase 2)
Pneumonia, Pneumococcal (Phase 4)
Pneumonia, Staphylococcal (Phase 4)
Poliomyelitis (Phase 2)
Primary Immunodeficiency Diseases (Phase 4)
Psoriasis (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Respiratory Tract Diseases (Phase 1)
Respiratory Tract Infections (Phase 1)
Sjogren's Syndrome (Phase 4)
Splenectomy (Phase 2)
Streptococcal Infections (Phase 3)
Streptococcus pneumoniae (Phase 4)
Systemic Vasculitis (Phase 4)
Tetanus (Phase 2)
Thalassemia (Phase 4)
Transplants (Phase 4)
Urinary Bladder Neoplasms (Phase 1)
Vaccination (Phase 4)
Vaccines (Phase 4)
Whooping Cough (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue